In retrospect, this is perhaps not surprising since there is no evidence that GBA carriers (i.e. heterozygotes) display Gaucher disease symptoms which would reflect changes in GlcCer levels, and there is, therefore, no reason to assume that PD patients with a heterozygous GBA mutation would present with elevated GlcCer levels. The gene discussed is GBA1; the disease is Parkinson disease.